Answers are grounded in this paper and cite their sources.
Analysis reveals BK polyomavirus genetic variation in transplant recipients undergoing VST therapy, indicating implications for immune response.
BK polyomavirus (BKPyV) can cause disease in transplant recipients. Virus-specific T-cell (VST) therapy is effective in decreasing virus levels in many individuals. BKPyV genetic variation can impact replication kinetics and immune responses. Here, we present the near full-length BKPyV genome sequences from two VST recipients in which genotype IV was isolated.
No takes yet. Share an insight, caveat, or question.
Walder et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: